Dr Lisa Barbaro is a medicinal chemist specializing in CNS drug discovery, with a focus on advancing small-molecule therapeutics for neurological and neurodegenerative disorders. She earned her PhD in Medicinal Chemistry at the Monash Institute of Pharmaceutical Sciences (Monash University, Australia), and has since worked at Vanderbilt University’s Warren Center for Neuroscience Drug Discovery (WCNDD), where she contributes to multidisciplinary programs targeting GPCRs, ion channels, and other emerging CNS targets. Her work is driven by a commitment to innovation in neuroscience and the development of safer, more effective therapeutics for brain disorders.